Galectin Therapeutics (GALT) Receivables - Other (2010)

Galectin Therapeutics (GALT) recorded quarterly Receivables - Other of $234000.0 in Q4 2010.

Galectin Therapeutics (GALT) Receivables - Other (2010) Analysis & Trends

Galectin Therapeutics' Receivables - Other history runs 1 years deep, the most recent figure standing at $234000.0 for Q4 2010.

In Q4 2010, Receivables - Other changed N/A year-over-year to $234000.0; the TTM figure through Dec 2010 stood at $234000.0 (changed N/A YoY), while the FY2010 annual figure was $234000.0, changed N/A from the prior year.
Receivables - Other was $234000.0 for Q4 2010 at Galectin Therapeutics.
In the past five years, Receivables - Other ranged from a high of $234000.0 in Q4 2010 to a low of $234000.0 in Q4 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Galectin Therapeutics	185.83 Mn	171.73 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2010	234,000.00
Dec 31, 2010	234,000.00